Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin pharmacokinetics in healthy volunteers with SLCO1B1 and ABCG2 variants
ChiCTR-ONC-10001058Phase 4Completed
- Sponsor
- Pharmacogenetics Research Institute, Xiangya Hospital, Central South University
- Start
- Oct 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rosuvastatin in hyperlipidemia, sponsored by Pharmacogenetics Research Institute, Xiangya Hospital, Central South University. Primary endpoint: Pharmacokinetic parameters. Started Oct 2010; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on ChiCTR-ONC-10001058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-10001058.